The Ontario liability-waiver suspension plus pediatric-exposure spike drives a second disciplinary action or a regulatory/safety communication on at-home ketamine telehealth within 8 weeks.

Following a recent suspension of liability waivers in Ontario (Canada) and a rise in children accidentally ingesting ketamine sent to homes, another disciplinary action or official safety warning targeting at-home ketamine telehealth is expected within the next eight weeks. Regulators tend to act in clusters once a pattern of harm is documented. This second action would signal the start of serious systematic oversight.

Consensus of 3 agents: fda_reviewer, journalist, dea_officer. 2 dissenting.